317 related articles for article (PubMed ID: 26598604)
1. LMO2 Oncoprotein Stability in T-Cell Leukemia Requires Direct LDB1 Binding.
Layer JH; Alford CE; McDonald WH; Davé UP
Mol Cell Biol; 2016 Feb; 36(3):488-506. PubMed ID: 26598604
[TBL] [Abstract][Full Text] [Related]
2. LDB1 Enforces Stability on Direct and Indirect Oncoprotein Partners in Leukemia.
Layer JH; Christy M; Placek L; Unutmaz D; Guo Y; Davé UP
Mol Cell Biol; 2020 May; 40(12):. PubMed ID: 32229578
[TBL] [Abstract][Full Text] [Related]
3. Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex.
El Omari K; Hoosdally SJ; Tuladhar K; Karia D; Vyas P; Patient R; Porcher C; Mancini EJ
Blood; 2011 Feb; 117(7):2146-56. PubMed ID: 21076045
[TBL] [Abstract][Full Text] [Related]
4. LMO2 promotes the development of AML through interaction with transcription co-regulator LDB1.
Lu L; Wang J; Fang F; Guo A; Jiang S; Tao Y; Zhang Y; Li Y; Zhang K; Zhang Z; Zhuo R; Chu X; Li X; Tian Y; Ma L; Sang X; Chen Y; Yu J; Yang Y; Cao H; Gao J; Lu J; Hu S; Pan J; He H
Cell Death Dis; 2023 Aug; 14(8):518. PubMed ID: 37573405
[TBL] [Abstract][Full Text] [Related]
5. Solution structure of a tethered Lmo2(LIM2) /Ldb1(LID) complex.
Dastmalchi S; Wilkinson-White L; Kwan AH; Gamsjaeger R; Mackay JP; Matthews JM
Protein Sci; 2012 Nov; 21(11):1768-74. PubMed ID: 22936624
[TBL] [Abstract][Full Text] [Related]
6. The LIM-domain binding protein Ldb1 and its partner LMO2 act as negative regulators of erythroid differentiation.
Visvader JE; Mao X; Fujiwara Y; Hahm K; Orkin SH
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13707-12. PubMed ID: 9391090
[TBL] [Abstract][Full Text] [Related]
7. Enforced expression of E47 has differential effects on Lmo2-induced T-cell leukemias.
Goodings C; Tripathi R; Cleveland SM; Elliott N; Guo Y; Shyr Y; Davé UP
Leuk Res; 2015 Jan; 39(1):100-9. PubMed ID: 25499232
[TBL] [Abstract][Full Text] [Related]
8. Identification of the key LMO2-binding determinants on Ldb1.
Ryan DP; Sunde M; Kwan AH; Marianayagam NJ; Nancarrow AL; Vanden Hoven RN; Thompson LS; Baca M; Mackay JP; Visvader JE; Matthews JM
J Mol Biol; 2006 May; 359(1):66-75. PubMed ID: 16616188
[TBL] [Abstract][Full Text] [Related]
9. A DNA-binding mutant of TAL1 cooperates with LMO2 to cause T cell leukemia in mice.
Draheim KM; Hermance N; Yang Y; Arous E; Calvo J; Kelliher MA
Oncogene; 2011 Mar; 30(10):1252-60. PubMed ID: 21057528
[TBL] [Abstract][Full Text] [Related]
10. LIM domain only-2 (LMO2) induces T-cell leukemia by two distinct pathways.
Smith S; Tripathi R; Goodings C; Cleveland S; Mathias E; Hardaway JA; Elliott N; Yi Y; Chen X; Downing J; Mullighan C; Swing DA; Tessarollo L; Li L; Love P; Jenkins NA; Copeland NG; Thompson MA; Du Y; Davé UP
PLoS One; 2014; 9(1):e85883. PubMed ID: 24465765
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Lhx2 suppresses proliferation of human T cell acute lymphoblastic leukemia-derived cells, partly by reducing LMO2 protein levels.
Miyashita K; Kitajima K; Goyama S; Kitamura T; Hara T
Biochem Biophys Res Commun; 2018 Jan; 495(3):2310-2316. PubMed ID: 29278703
[TBL] [Abstract][Full Text] [Related]
12. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia.
Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE
Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817
[TBL] [Abstract][Full Text] [Related]
13. Identification of DeltaEF1 as a novel target that is negatively regulated by LMO2 in T-cell leukemia.
Sun W; Yang S; Shen W; Li H; Gao Y; Zhu TH
Eur J Haematol; 2010 Dec; 85(6):508-19. PubMed ID: 20731704
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic LMO2-LDB1 Complex Activates STAT3 Signaling through Interaction with gp130-JAK in Glioma Stem Cells.
Park CG; Choi SH; Lee SY; Eun K; Park MG; Jang J; Jeong HJ; Kim SJ; Jeong S; Lee K; Kim H
Cells; 2022 Jun; 11(13):. PubMed ID: 35805116
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for the recognition of ldb1 by the N-terminal LIM domains of LMO2 and LMO4.
Deane JE; Mackay JP; Kwan AH; Sum EY; Visvader JE; Matthews JM
EMBO J; 2003 May; 22(9):2224-33. PubMed ID: 12727888
[TBL] [Abstract][Full Text] [Related]
16. Design, production and characterization of FLIN2 and FLIN4: the engineering of intramolecular ldb1:LMO complexes.
Deane JE; Sum E; Mackay JP; Lindeman GJ; Visvader JE; Matthews JM
Protein Eng; 2001 Jul; 14(7):493-9. PubMed ID: 11522923
[TBL] [Abstract][Full Text] [Related]
17. Crystal structure of human LDB1 in complex with SSBP2.
Wang H; Kim J; Wang Z; Yan XX; Dean A; Xu W
Proc Natl Acad Sci U S A; 2020 Jan; 117(2):1042-1048. PubMed ID: 31892537
[TBL] [Abstract][Full Text] [Related]
18. Purification, crystallization and preliminary X-ray analysis of a fusion of the LIM domains of LMO2 and the LID domain of Ldb1.
El Omari K; Porcher C; Mancini EJ
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2010 Nov; 66(Pt 11):1466-9. PubMed ID: 21045296
[TBL] [Abstract][Full Text] [Related]
19. Tandem LIM domains provide synergistic binding in the LMO4:Ldb1 complex.
Deane JE; Ryan DP; Sunde M; Maher MJ; Guss JM; Visvader JE; Matthews JM
EMBO J; 2004 Sep; 23(18):3589-98. PubMed ID: 15343268
[TBL] [Abstract][Full Text] [Related]
20. Elucidation of the role of LMO2 in human erythroid cells.
Inoue A; Fujiwara T; Okitsu Y; Katsuoka Y; Fukuhara N; Onishi Y; Ishizawa K; Harigae H
Exp Hematol; 2013 Dec; 41(12):1062-76.e1. PubMed ID: 24041784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
